We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
AUM
$1.84B
AUM Growth
-$480M
Cap. Flow
-$470M
Cap. Flow %
-25.56%
Top 10 Hldgs %
46.94%
Holding
98
New
25
Increased
8
Reduced
28
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 91.78%
2 Consumer Discretionary 2.94%
3 Financials 1.26%
4 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARYE
51
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$4.85M 0.26%
500,000
CYTK icon
52
Cytokinetics
CYTK
$10.4B
$4.29M 0.23%
94,120
-340,380
-78% -$13.1M
HALO icon
53
Halozyme
HALO
$12B
$4.2M 0.23%
104,482
-389,020
-79% -$14.5M
STXS icon
54
Stereotaxis
STXS
$140M
$4.07M 0.22%
+656,540
New +$3.92M
INSP icon
55
Inspire Medical Systems
INSP
$1.73B
$4.02M 0.22%
+17,490
New +$4.27M
IMA
56
ImageneBio Inc
IMA
$63M
$3.61M 0.2%
23,968
-4,361
-15% -$707K
MRUS
57
DELISTED
Merus
MRUS
$3.55M 0.19%
111,760
+40,862
+58% +$1.15M
CYPH
58
Cypherpunk Technologies Inc
CYPH
$73.9M
$3.46M 0.19%
106,669
-13,331
-11% -$370K
AXNX
59
DELISTED
Axonics, Inc. Common Stock
AXNX
$3.3M 0.18%
+58,920
New +$3.6M
PYXS icon
60
Pyxis Oncology
PYXS
$231M
$2.69M 0.15%
+244,838
New +$2.8M
OHPA
61
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
$1.95M 0.11%
199,751
-347,634
-64% -$3.39M
DICE
62
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$1.89M 0.1%
74,774
+31,974
+75% +$937K
LGV.WS
63
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$363K 0.02%
427,178
BBIO icon
64
CALL
BridgeBio Pharma
BBIO
$16.3B
$167K 0.01%
+10,000
New +$423K
EQRXW
65
DELISTED
EQRx, Inc. Warrant
EQRXW
$107K 0.01%
99,998
OHPAW
66
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$89K ﹤0.01%
137,305
MSACW
67
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$60K ﹤0.01%
82,663
EUCRW
68
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$45K ﹤0.01%
+78,059
New +$57.4K
ALGN icon
69
Align Technology
ALGN
$12.2B
-46,730
Closed -$31.1M
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$29B
-7,510
Closed -$1.42M
ATAI icon
71
AtaiBeckley Inc
ATAI
$2.68B
-75,000
Closed -$1.11M
AVIR icon
72
Atea Pharmaceuticals
AVIR
$412M
-36,580
Closed -$1.28M
BDX icon
73
Becton Dickinson
BDX
$48.6B
-144,054
Closed -$34.5M
BNTX icon
74
BioNTech
BNTX
$23.3B
-23,690
Closed -$6.47M
CI icon
75
Cigna
CI
$74.3B
-211,780
Closed -$42.4M

Similar funds

HealthCor Management's Q4 2021 Portfolio in Review

As of Q4 2021, HealthCor Management held 98 positions worth $1.84B, down 21% from $2.32B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

HealthCor Management withdrew a net $470M in Q4 2021, closing 30 positions and reducing 28 holdings. Its most notable exit was Welltower, an estimated $50.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 89% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, HealthCor Management opened a new position in Danaher worth $49.5M.

  • HealthCor Management's largest Q4 2021 buy was Danaher: 169,866 shares worth $49.5M.
  • HealthCor Management added most to Medtronic in Q4 2021, an estimated $106M increase.
  • HealthCor Management's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $104M.
  • HealthCor Management fully exited Welltower in Q4 2021, selling an estimated $50.9M.
  • HealthCor Management's ten largest holdings make up 47% of its $1.84B portfolio in Q4 2021.
  • HealthCor Management opened 25 new positions and closed 30 in Q4 2021.
  • HealthCor Management's portfolio value fell 21% quarter-over-quarter to $1.84B.

Based on HealthCor Management's 13F filing for Q4 2021, filed 14 Feb 2022.